105 related articles for article (PubMed ID: 2214236)
1. [The correlations of respiratory function tests, chest roentgenographic manifestations and respiratory symptoms in the patients with systemic sclerosis, using a scoring-method for symptoms].
Kikuchi K; Igarashi A; Ishibashi Y; Inokuma S; Takehara K
Nihon Hifuka Gakkai Zasshi; 1990 May; 100(6):695-700. PubMed ID: 2214236
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary changes in progressive systemic sclerosis].
Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary functions in children with progressive systemic sclerosis.
Garty BZ; Athreya BH; Wilmott R; Scarpa N; Doughty R; Douglas SD
Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
[TBL] [Abstract][Full Text] [Related]
5. Latent pulmonary inflammation in patients with systemic sclerosis.
Sánchez-Vidaurre S; Simeón CP; Cruz MJ; Fonollosa V; Vilardell M; Morell F; Muñoz X
Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary functions in patients with progressive systemic sclerosis].
Takaya M; Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Arimori S
Ryumachi; 1994 Feb; 34(1):2-9. PubMed ID: 8146723
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
8. Assessments of pulmonary involvement in patients with systemic sclerosis.
Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
11. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
[TBL] [Abstract][Full Text] [Related]
13. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.
Vañó Sanchis D; Arranz Garcia G; Yglesias PJ
Clin Rheumatol; 2006 May; 25(3):382-3. PubMed ID: 16211337
[No Abstract] [Full Text] [Related]
15. [Collageno-vascular diseases and interstitial pulmonary fibrosis. An analysis of diagnostic tests].
Baldi S; Rapellino M; Libertucci D; Obert R; Scappaticci E; Coni F; Revello F; Oliaro A; Botto-Micca F
Minerva Med; 1987 Sep; 78(17):1277-80. PubMed ID: 3670681
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography.
Sperandeo M; De Cata A; Molinaro F; Trovato FM; Catalano D; Simeone A; Varriale A; Martines GF; Trovato G
Scand J Rheumatol; 2015; 44(5):389-98. PubMed ID: 26099251
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary involvement in systemic sclerosis].
Ioanăş M
Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
[No Abstract] [Full Text] [Related]
19. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
Wells AU; Steen V; Valentini G
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary function in patients with systemic sclerosis.
Spagnolatti L; Zoia MC; Volpini E; Convertino G; Fulgoni P; Corsico A; Vitulo P; Cerveri I
Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
